Potential Sources and Roles of Adaptive Immunity in Age-Related Macular Degeneration: Shall We Rename AMD into Autoimmune Macular Disease?
Age-related macular degeneration (AMD) is the leading cause of vision loss in the elderly throughout the industrialized world. Its most prominent pathologic features are lesions involving the retinal pigment epithelium (RPE) the Bruch’s membrane, the degeneration of photoreceptors, and, in the most...
Main Author: | Serge Camelo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Autoimmune Diseases |
Online Access: | http://dx.doi.org/10.1155/2014/532487 |
Similar Items
-
Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
by: Sonali Nashine
Published: (2021-09-01) -
Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
by: Luis García-Onrubia, et al.
Published: (2020-08-01) -
Prevention and treatment of Age-related Macular Degeneration (AMD)
by: Dornstauder, Blake
Published: (2011) -
Targeted therapy in age-related macular degeneration (AMD)
by: Klaudia Daria Szumna, et al.
Published: (2020-03-01) -
Genetic risk factors and age-related macular degeneration (AMD)
by: Maryam Mousavi, et al.
Published: (2013-10-01)